Company announces appointment of Nomura Code Securities Limited as Nominated Adviser and sole broker NEW YORK, May 16
NEW YORK, May 16 /PRNewswire-FirstCall/ -- Medicsight PLC, a subsidiary of
MGT Capital Investments, Inc. (Amex: MGT) (the "Company"), and an industry
leader in the development of Computer-Aided Detection (CAD) and image analysis
software which assists in the early detection and diagnosis of disease, today
announced the appointment of NM Rothschild & Sons Limited ("Rothschild"), a
leading international investment bank, as corporate adviser to the Company,
effective immediately.
Rothschild has been appointed by Medicsight to offer independent advice
and help to develop corporate opportunities. As stated in the Company's AIM
Admission document, one of Medicsight's objectives over the next one to two
years is to seek strategic merger and acquisition opportunities in order to
introduce additional products into its portfolio.
Tim Paterson-Brown, MGT Chairman and CEO, stated, "We are pleased to
announce the appointment of Rothschild, and welcome their independent and
strategic advice. They have a strong healthcare team in place, with which we
look forward to building a long and successful working relationship.
"In order to take advantage of the tremendous opportunities our existing
technologies offer, we are required to have an experienced and knowledgeable
team in place. We are confident that Rothschild will prove to be of
tremendous value to our Company in building upon our existing technologies and
identify new opportunities."
In addition, Medicsight announced the appointment of Nomura Code
Securities Limited as Nominated Adviser (NOMAD) and sole broker to the Company
effective immediately.
"Our Board is impressed by Nomura Code's market knowledge and specialist
investor contacts within the healthcare sector. Nomura Code also has
significant outreach in Japan, which will be very beneficial to Medicsight as
we penetrate the Asian market and continue to develop a strong relationship
with Toshiba," concluded Mr. Paterson-Brown.
About MGT Capital Investments, Inc.
MGT Capital Investments, Inc is a holding company that focuses on
investments in the global healthcare information technology market. The
Company has two subsidiaries, Medicsight PLC and Medicexchange PLC.
Medicsight PLC (AIM: MDST) is a leading developer of computer-aided
detection (CAD) software solutions. Medicsight's CAD solutions help clinicians
utilizing Computed Tomography (CT) scans to identify, measure and analyze
suspicious pathology within the colon and lungs. The Medicsight CAD products
are validated against one of the world's largest databases of verified CT scan
data collected from leading healthcare institutions from around the world.
Medicsight products allow radiologists and physicians to review scans more
quickly and accurately -- saving both time and lives.
Medicexchange PLC provides medical imaging professionals with a global web
portal containing an online sales, jobs and information channel for
diagnostic, treatment and surgery planning solutions. This combined with a
variety of relevant clinical papers, training materials and content gives
these professionals access to information and products that they otherwise
would have difficulty accessing.
Additional information can be found at www.mgtci.com.
All forward-looking statements are made pursuant to the 'safe harbor'
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are based on current management expectations that
involve risks and uncertainties that may result in such expectations not being
realized. Potential risks and uncertainties include, but are not limited to,
the risks described in company filings with the Securities and Exchange
Commission.
SOURCE MGT Capital Investments, Inc.
